Drug Interaction Report

Belumosudil and Primidone: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 15, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Primidone

Mysoline
+

Belumosudil

Rezurock Rezurock®
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 11, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 88 documented Belumosudil interactions, 70 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be weaker
The Bottom Line
Primidone may speed up how your body breaks down belumosudil, which could make the belumosudil less effective. Don't stop either drug on your own; ask your care team, who can adjust the belumosudil dose and monitor you.

Here's what's going on. Primidone (Mysoline) can speed up a liver pathway called CYP3A. Belumosudil (Rezurock) is broken down by that same pathway. So taking them together may cause your body to clear the belumosudil faster, leaving less of it in your system. That could make the belumosudil work less well against your graft-versus-host disease.

The good news is this is mostly a theoretical concern based on how these drugs behave, not something reported in every patient. Please don't change anything on your own. Your care team can manage this by adjusting your dose and watching how you respond, so bring it up at your next visit.

Mechanism: Primidone (partly via its phenobarbital metabolite) is a CYP3A4 inducer. Belumosudil is a CYP3A4 substrate, so co-administration may increase its metabolism.

Direction/effect: Reduced belumosudil exposure (decreased AUC/Cmax) and potentially reduced efficacy. Belumosudil is an active drug, not a prodrug, so induction lowers, not raises, its effect.

  • Severity: Major
  • Onset: Unspecified (enzyme induction typically develops over days to weeks)
  • Evidence: Theoretical

Management: Avoid the combination if possible. If unavoidable, the belumosudil dose may need to be individualized upward and clinical response monitored more closely.

Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

Reduced CYP3A substrate exposure and reduced efficacy of CYP3A substrate

Interaction Deep Dive

When PHENobarbital, which acts as a CYP3A inducer, is administered together with a CYP3A substrate, the exposure to that substrate may fall, potentially diminishing its therapeutic effect. In situations where combined use is unavoidable, neonates should be watched carefully, and raising the dose of the CYP3A substrate as needed should be considered1.

Why it happens (mechanism)

Induction of CYP3A-mediated metabolism of CYP3A substrates

How to manage this interaction

Keep taking both medicines as prescribed unless your care team tells you otherwise. This interaction can usually be managed.

  • Your team may consider whether the combination can be avoided, since a strong enzyme inducer can lower belumosudil levels.
  • If both are needed, your belumosudil dose may be adjusted and individualized by your care team.
  • They may monitor you more closely to be sure the belumosudil is still controlling your condition.

What to do: Tell your pharmacist and prescriber that you take both, and report any signs your GVHD symptoms are returning or worsening.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Belumosudil and Primidone together?

Primidone may speed up how your body breaks down belumosudil, which could make the belumosudil less effective. Don't stop either drug on your own; ask your care team, who can adjust the belumosudil dose and monitor you. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Belumosudil and Primidone interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Belumosudil and Primidone interaction managed?

Keep taking both medicines as prescribed unless your care team tells you otherwise. This interaction can usually be managed. Your team may consider whether the combination can be avoided, since a strong enzyme inducer can lower belumosudil levels. If both are needed, your belumosudil dose may be adjusted and individualized by your care team. They may monitor you more closely to be sure the belumos… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

From our Q&A

Real reader questions about these medications, each personally answered by our pharmacist:

Questions for your pharmacist

  • Does my dose of Belumosudil or Primidone need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (1)

  1. Product Information: SEZABY(TM) intravenous injection, phenobarbital sodium intravenous injection. Sun Pharmaceutical Industries Inc (per manufacturer), Cranbury, NJ, 2022. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.